Secretin - Eisai
Alternative Names: E 0286; SecrepanLatest Information Update: 24 Oct 2021
At a glance
- Originator Eisai Co Ltd
- Class Antipsychotics; Behavioural disorder therapies; Gastrointestinal hormones; Neuropeptides; Peptide diagnostics; Peptide hormones
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bleeding ulcer
Most Recent Events
- 12 Jul 1995 Discontinued-II for Bleeding ulcer in Japan (Unknown route)